enlightenbio  Blog

Industry News in Genomics, Genetics, Precision Medicine, and Beyond

Find here a listing of the latest industry news in genomics, genetics, precision medicine, and beyond. We will update and add to this page on a regular basis. This page is not a compilation of all relevant information but rather contains some key highlights that we consider to be of importance to share with the community.

Sign-Up for our newsletter and never miss out on the latest news and updates.

Check out our News Dashboard with real-time listing of news and articles in genomics, genetics, precision medicine, and beyond.

News for the month of March 2023

Funding / IPO

Mergers & Acquisitions

Genomic/Genetic Testing/CDx/Liquid Biopsy

(Genomics) Data Platform / Sequencing / Analysis / Instruments

Artificial Intelligence / Machine Learning

Miscellaneous

Silicon Valley Bank

Publications

News for the month of February 2023

Funding & IPO

Precision / Genomic Medicine

(Genomics) Data Platform / Analysis / Instruments

  • Element to Present Data and Innovation Roadmap at AGBT As per their press release: With its new Cloudbreak chemistry coming in April, Element is accelerating the power of sequencing with 20 percent faster runs and a simplified workflow with Elevate linear libraries, all with superior accuracy at the industry’s lowest cost. Element provides the highest quality sequencing on a benchtop for as low as $200 a genome, or $2 per gigabase.

(Genomics) Data Platform / Analysis / Instruments

Artificial Intelligence / Machine Learning

RWE / RWD

Miscellaneous

COVID-19 / SARS-CoV-2

Publications

News for the month of January 2023

January started off with the 41st edition of the annual JP Morgan Healthcare conference which typically provides a rich source of news across the healthcare sector, including updates on mergers and acquisitions. This year we learned about the formation of Velsera as a result of combining Seven Bridges with PierianDx and Urgentec. Velsera’s goal is to create a software platform out of science, technology, and informatics, making data actionable, accelerating the pace and including the potential of multi-omics. A more detailed summary of newsworthy activities in the various therapeutic areas can be found in Insights and Key Takeaways of the JP Morgan Healthcare Conference.

Another not too surprising highlight included Nature Methods calling long-read sequencing the Method of the year 2022, this after the success of the Telomere-to-Telomere (T2T) Consortium presenting the first ever complete human genome using long-read sequencing. The two most widely used commercial technologies are Pacific Biosciences’ Single Molecule Real-Time (SMRT) sequencing (average read length ~20 kb with >99.9% accuracy for HiFi reads) and Oxford Nanopore Technologies’ nanopore sequencing (average read length ~100 kb for ultra-long reads, ~99% accuracy for R10.4).

Additional news included Alphabet’s Verily announcing layoffs amid strategic restructuringSema4 Announcing name change to GeneDx, and the launch of the clinical trial company Paradigm with $203M in funding to build a clinical research platform for provider and pharma customers.

Funding & IPO

Mergers & Acquisitions

Precision Medicine

(Genomics) Data Platform / Analysis / Instruments

Genomic/Genetic Testing/CDx/Liquid Biopsy

CRISPR / Cas9

  • Crispr Wants to Feed the World The power to fight human diseases put genome editing on the map. But similar technology could help crops withstand the stress of climate change.

Artificial Intelligence / Machine Learning

Miscellaneous

Cancer Vaccines

COVID-19 / SARS-CoV-2

Publications

Following are archived industry news

Industry News – 2022

Industry News – 2021

Industry News – 2020

Industry News – 2019

Industry News – 2018

Industry News – 2017

COVID-19 / SARS-CoV-2

Collated COVID-19/SARS-CoV-2 Information

ADVERTISEMENT

Your Header Sidebar area is currently empty. Hurry up and add some widgets.

%d bloggers like this: